Fingerprinting of the TLR4-induced acute inflammatory response

被引:22
作者
Bosmann, Markus [1 ,2 ,3 ]
Russkamp, Norman F. [1 ]
Ward, Peter A. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany
[3] Univ Med Ctr, Dept Hematol & Oncol, Mainz, Germany
基金
美国国家卫生研究院;
关键词
Endotoxemia; Shock; LPS; Acute lung injury; Bead-based assay; TUMOR-NECROSIS-FACTOR; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; SEPTIC SHOCK; DOUBLE-BLIND; ENDOTOXIN; LIPOPOLYSACCHARIDE; RECEPTOR; SEPSIS; MICE;
D O I
10.1016/j.yexmp.2012.08.006
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Intensive scientific efforts in the past decades have helped shed light into the pathogenesis of endotoxin-induced inflammation. We have used multiplexing bead-based assays to characterize the responses in two models of in vivo LPS challenge. C57BL16 mice were either injected intraperitoneally (endotoxemia) or intratracheally (acute lung injury: ALI) with lipopolysaccharide (LPS). The time courses (1 h-24 h) of the following 20 inflammatory mediators in plasma or broncho-alveolar lavages were simultaneously analyzed: IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-12(p40), IL-13, Eotaxin (CCL11), G-CSF, GM-SF, IFN-gamma y, KC (CXCL1), MCP-1 (CCL2), MIP-1 alpha (CCL3), MIP-1 beta (CCL4), RANTES (CCL5) and TNF-alpha. While significant inductions of all mediators were found, substantial differences in their absolute concentrations, time points of maximal concentrations and clearances were observed. There were also notable variations in the patterns of several cytokines/chemokines when samples from endotoxemia and LPS-ALI were compared. These data may be helpful in defining analytic strategies including selection of optimal time points for studying the host immune response to endotoxin. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:319 / 323
页数:5
相关论文
共 24 条
[1]   EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].
ABRAHAM, E ;
WUNDERINK, R ;
SILVERMAN, H ;
PERL, TM ;
NASRAWAY, S ;
LEVY, H ;
BONE, R ;
WENZEL, RP ;
BALK, R ;
ALLRED, R ;
PENNINGTON, JE ;
WHERRY, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941
[2]  
Abraham E, 1998, LANCET, V351, P929
[3]   Genetic polymorphisms in the endotoxin receptor may influence platelet count as part of the acute phase response in critically ill children [J].
Agbeko, Rachel S. ;
Holloway, John W. ;
Allen, Meredith L. ;
Ye, Shu ;
Fidler, Katy J. ;
Pappachan, John ;
Goldman, Allan ;
Pontefract, David ;
Deanfield, John ;
Klein, Nigel J. ;
Peters, Mark J. .
INTENSIVE CARE MEDICINE, 2010, 36 (06) :1023-1032
[4]   Innate immune sensing and its roots: the story of endotoxin [J].
Beutler, B ;
Rietschel, ET .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (02) :169-176
[5]   Complement Activation Product C5a Is a Selective Suppressor of TLR4-Induced, but Not TLR3-Induced, Production of IL-27(p28) from Macrophages [J].
Bosmann, Markus ;
Haggadone, Mikel D. ;
Hemmila, Mark R. ;
Zetoune, Firas S. ;
Sarma, J. Vidya ;
Ward, Peter A. .
JOURNAL OF IMMUNOLOGY, 2012, 188 (10) :5086-5093
[6]   Anti-inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury [J].
Bosmann, Markus ;
Grailer, Jamison J. ;
Zhu, Ketong ;
Matthay, Michael A. ;
Sarma, J. Vidya ;
Zetoune, Firas S. ;
Ward, Peter A. .
FASEB JOURNAL, 2012, 26 (05) :2137-2144
[7]   THE OUTCOME OF POLYMICROBIAL SEPSIS IS INDEPENDENT OF T AND B CELLS [J].
Bosmann, Markus ;
Russkamp, Norman F. ;
Patel, Vinay R. ;
Zetoune, Firas S. ;
Sarma, J. Vidya ;
Ward, Peter A. .
SHOCK, 2011, 36 (04) :396-401
[8]   Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide [J].
Chen, Li ;
Arora, Meenakshi ;
Yarlagadda, Manohar ;
Oriss, Timothy B. ;
Krishnamoorthy, Nandini ;
Ray, Anuradha ;
Ray, Prabir .
JOURNAL OF IMMUNOLOGY, 2006, 177 (04) :2373-2383
[9]   Acute inflammatory response to endotoxin in mice and humans [J].
Copeland, S ;
Warren, HS ;
Lowry, SF ;
Calvano, SE ;
Remick, D .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (01) :60-67
[10]   Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein [J].
Fisher, CJ ;
Agosti, JM ;
Opal, SM ;
Lowry, SF ;
Balk, RA ;
Sadoff, JC ;
Abraham, E ;
Schein, RMH ;
Benjamin, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1697-1702